These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36926672)

  • 1. Prevention of Gallstones After Bariatric Surgery using Ursodeoxycholic Acid: A Narrative Review of Literatures.
    Son SY; Song JH; Shin HJ; Hur H; Han SU
    J Metab Bariatr Surg; 2022 Dec; 11(2):30-38. PubMed ID: 36926672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis.
    Ying J; Dai S; Fu R; Hong J; Dai C; Jin Q
    Obesity (Silver Spring); 2022 Jun; 30(6):1170-1180. PubMed ID: 35475596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials.
    Fearon NM; Kearns EC; Kennedy CA; Conneely JB; Heneghan HM
    Surg Obes Relat Dis; 2022 Jan; 18(1):77-84. PubMed ID: 34772614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
    Mulliri A; Menahem B; Alves A; Dupont B
    J Gastroenterol; 2022 Aug; 57(8):529-539. PubMed ID: 35704084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
    Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis.
    Magouliotis DE; Tasiopoulou VS; Svokos AA; Svokos KA; Chatedaki C; Sioka E; Zacharoulis D
    Obes Surg; 2017 Nov; 27(11):3021-3030. PubMed ID: 28889240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
    Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
    Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
    Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
    Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.
    Haal S; Guman MSS; Bruin S; Schouten R; van Veen RN; Fockens P; Dijkgraaf MGW; Hutten BA; Gerdes VEA; Voermans RP
    Obes Surg; 2022 Apr; 32(4):1270-1278. PubMed ID: 35143012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic Acid Prophylaxis and the Reduction of Gallstone Formation After Bariatric Surgery: An Updated Meta-Analysis of Randomized Controlled Trials.
    Al-Huniti M; Alsardia Y; Odeh A; Bdour B; Hassanat R; Aloun A; Sha'ban BW; Nseirat SM
    Cureus; 2023 Dec; 15(12):e50649. PubMed ID: 38229797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Ursodeoxycholic Acid in the Prevention of Gallstones Formation in Bariatric Patients-a Systematic Review and Meta-Analysis of Randomised Trials.
    Sharma A; Shanti H; Nageswaran H; Best LMJ; Patel AG
    Obes Surg; 2023 Dec; 33(12):4115-4124. PubMed ID: 37872257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
    Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
    Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis.
    Uy MC; Talingdan-Te MC; Espinosa WZ; Daez ML; Ong JP
    Obes Surg; 2008 Dec; 18(12):1532-8. PubMed ID: 18574646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Ursodeoxycholic Acid (UDCA) in Cholelithiasis Management After One Anastomosis Gastric Bypass (OAGB) for Morbid Obesity: Results of a Monocentric Randomized Controlled Trial.
    Pizza F; D'Antonio D; Lucido FS; Tolone S; Del Genio G; Dell'Isola C; Docimo L; Gambardella C
    Obes Surg; 2020 Nov; 30(11):4315-4324. PubMed ID: 32583297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study.
    Barzin M; Andalib A; Khalaj A; Mahdavi M; Valizadeh M; Mousapour P; Hosseinpanah F
    Obes Surg; 2022 Feb; 32(2):311-317. PubMed ID: 34816356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased gallstone formation after sleeve gastrectomy and the preventive role of ursodeoxycholic acid.
    Vural A; Goksu K; Kahraman AN; Boy FN; Anil BS; Fersahoglu MM
    Acta Gastroenterol Belg; 2020; 83(1):33-38. PubMed ID: 32233269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics for gallstone prevention in patients with bariatric surgery: A prospective randomized trial.
    Han ML; Lee MH; Lee WJ; Chen SC; Almalki OM; Chen JC; Wu CC
    Asian J Surg; 2022 Dec; 45(12):2664-2669. PubMed ID: 35232647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers.
    Guman MSS; Haal S; Acherman YIZ; van de Laar AWL; Nieuwdorp M; Voermans RP; Gerdes VEA
    Obes Surg; 2023 Jun; 33(6):1773-1781. PubMed ID: 37186289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective.
    Hossain I; Brodie J; O'Brien E; Tedman-Aucoin K; Lawlor D; Murphy R; Twells L; Pace D; Evans B; Ellsmere J
    Surg Endosc; 2023 Jul; 37(7):5236-5240. PubMed ID: 36952047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.